CryoPort Inc (NASDAQ:CYRX) Director Richard J. Berman sold 30,000 shares of the business’s stock in a transaction dated Thursday, November 15th. The shares were sold at an average price of $10.06, for a total transaction of $301,800.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

CYRX stock opened at $10.47 on Monday. CryoPort Inc has a 12-month low of $6.66 and a 12-month high of $16.88. The stock has a market capitalization of $306.14 million, a price-to-earnings ratio of -30.79 and a beta of 1.42.

CryoPort (NASDAQ:CYRX) last released its quarterly earnings data on Thursday, November 8th. The consumer goods maker reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.01. CryoPort had a negative net margin of 55.44% and a negative return on equity of 40.81%. The firm had revenue of $5.30 million for the quarter, compared to analysts’ expectations of $5.06 million. During the same quarter in the previous year, the company earned $0.08 earnings per share. The company’s revenue for the quarter was up 76.7% compared to the same quarter last year. As a group, equities research analysts expect that CryoPort Inc will post -0.33 EPS for the current fiscal year.

A number of equities analysts have issued reports on CYRX shares. BidaskClub upgraded shares of CryoPort from a “hold” rating to a “buy” rating in a research report on Tuesday, September 11th. Cowen boosted their price objective on shares of CryoPort from $11.00 to $16.00 and gave the company an “outperform” rating in a research report on Monday, August 13th. Finally, B. Riley started coverage on shares of CryoPort in a research report on Wednesday, October 10th. They issued a “buy” rating and a $22.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $19.75.

Several hedge funds have recently added to or reduced their stakes in the business. Strs Ohio bought a new stake in shares of CryoPort during the 2nd quarter valued at about $115,000. Metropolitan Life Insurance Co. NY bought a new stake in shares of CryoPort during the 2nd quarter valued at about $136,000. FNY Investment Advisers LLC bought a new stake in shares of CryoPort during the 3rd quarter valued at about $147,000. HRT Financial LLC bought a new stake in shares of CryoPort during the 3rd quarter valued at about $156,000. Finally, Greenwood Capital Associates LLC bought a new stake in shares of CryoPort during the 2nd quarter valued at about $163,000. Hedge funds and other institutional investors own 47.29% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Insider Selling: CryoPort Inc (CYRX) Director Sells 30,000 Shares of Stock” was originally published by Daily Political and is the property of of Daily Political. If you are reading this news story on another site, it was stolen and republished in violation of US and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dailypolitical.com/2018/11/19/insider-selling-cryoport-inc-cyrx-director-sells-30000-shares-of-stock.html.

CryoPort Company Profile

Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.

Featured Story: What is a stock buyback?

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.